SAG
NTLA icon

SageView Advisory Group’s Intellia Therapeutics NTLA Stock Holding History

SageView Advisory Group’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,345
Closed -$854K – 670
2024
Q1 		$854K Buy
+19,345
New +$854K 0.04% 222